[Sigsti-l] Fwd: Cell Press Announces Free Access to Recent On line Archive (fwd)
Brennen, Patrick
pbrennen at noble.org
Wed Aug 18 17:43:41 EDT 2004
Hello All,
Regarding Cell Press:
Yes, this is another sham bogus proposal by a publisher - it's called "open
access". Read the details about open access coming from various publishers,
because it will hit your pocketbooks big time. They are in business to make
money not to do charity work for your library. Open access is another way
that the publishers have devised to enhance their profits by additional
gouging of libraries and publishing authors.
Please note that there is an embargo on the latest 12 months of
CELL, so for heavy research oriented institutes such as ours, it makes this
"free access" totally worthless. I don't know of any good scientist that
wants information that is 12 months old. Almost all of our journals in our
Library are now full text online and we pay big time bucks for them. As
this "open access" concept unfolds from publishers, all that we can see in
it is additional costs to our library and institute thru new author fees and
through their Byzantine concept called "library membership fees" which
replace "subscriptions". We are projecting a 20% increase in our journal
costs when combined with the new "author fees" that publishers are
implementing as part of this.
Free access to their old backfiles (older than 12 months) is
virtually worthless in most cases to scientific and medical researchers who
are on the cutting edge and as such, worthless information to a publisher
has no value to them in terms of potential profits - hence they are
"graciously" providing access to it free.
Patrick W. Brennen, Director
Samuel Roberts Noble Foundation Library
2510 Sam Noble Parkway
Ardmore, Oklahoma 73401
www.noble.org
-----Original Message-----
From: Jon R Jablonski [mailto:jonjab at uoregon.edu]
Sent: Wednesday, August 18, 2004 4:11 PM
To: CHMINF-L at LISTSERV.INDIANA.EDU; sigsti-l at asis.org; STS-L at LISTSERV.UTK.EDU
Subject: [Sigsti-l] Fwd: Cell Press Announces Free Access to Recent Online
Archive (fwd)
I know it's a cliche, but: Please pardon cross posting.
To us, this is a major, major breakthrough, as Oregon has never been able
to afford any electronic access to this important set of journals.
-jon
Jon Jablonski 541-346-2871
Reference Librarian jonjab at uoregon.edu
University of Oregon Science Library
>*Please excuse the cross-posting*
>
>The following press release was issued today from Cell Press regarding
>free access to its recent archive of journals.
>
>Daviess Menefee
>Library Relations
>Elsevier
>
>PRESS RELEASE
>Cambridge, Massachusetts, USA
>August 18, 2004
>
>Cell Press is pleased to announce that access to the recent online archive
>of Cell and the other premier journals of the Cell Press collection will
>become freely available beginning in January 2005. The recent archive of
>these journals includes content that is 12 months old or older and dating
>back to content from 1995. Each month as new issues are published, the old
>issues will be added to the freely accessible recent archive. Free access
>to the recent archive will be available on both ScienceDirect
>(www.sciencedirect.com) and on the Cell Press journal sites
>(www.cellpress.com).
>
>Today's announcement by Cell Press represents an important change that
>will make a large part of the Cell Press journal archive freely accessible
>to the worldwide biomedical research community. Cell Press President and
>CEO Lynne Herndon commented, "Our main goal is the dissemination of
>information and the active support of scientific exchange. In recognition
>of the opportunities afforded by electronic publishing, Cell Press is
>taking this decision in order to better meet the needs of our unique
>author and reader communities. This opportunity also allows us to
>incorporate the notion of an open archive without adopting the
>pay-for-publication model that we believe is untested from both an
>editorial and financial perspective."
>
>Arie Jongejan, CEO Science & Technology, Elsevier added: "Cell Press
>publishes a suite of journals with a unique profile in biomedicine. Its
>readers expect science with immediate impact and its authors expect
>specialized care and extra speed. We support Cell Press' unique role in
>the life sciences and within Elsevier."
>
>Cell Press is committed to improving scientific communication through the
>publication of exciting biology research and reviews. Our mission is to
>continue to publish and develop journals that deliver the highest possible
>intellectual rigor, promote community trust, and are widely disseminated.
>To that end, we are pleased to be able to add our new policy to existing
>Elsevier initiatives:
>
>--Participation in the HINARI project of the WHO, which distributes
journals
> for free to developing countries
> (http://www.healthinternetwork.org/index.php);
>--A liberal copyright policy that gives authors broad rights;
>--Free advance online publication of selected papers;
>--Investment in making the entire back-issue collection available online;
>--Online submission and review for the convenience of authors and
reviewers;
>--Support of the research community via meeting sponsorships
>
>About Cell Press
>
>Cell Press, an imprint of Elsevier, publishes prestigious highly-cited
>biomedical research journals. Each Cell Press journal is a leading source
>for research in its field. The journals include Cell (www.cell.com),
>Neuron (www.neuron.org), Immunity (www.immunity.com), Molecular Cell
>(www.molecule.org), Developmental Cell (www.developmentalcell.com), Cancer
>Cell (www.cancercell.org), Current Biology (www.current-biology.com),
>Structure (www.structure.org), Chemistry & Biology (www.chembiol.com) and
>the new journal Cell Metabolism (www.cellmetabolism.org) which will launch
>in January 2005. The Cell Metabolism recent archive will become freely
>accessible beginning in January 2006.
>
>About Elsevier
>
>Elsevier is a world-leading publisher of scientific, technical and medical
>information products and services. Working in partnership with the global
>science and health communities, Elsevier's 6,800 employees in 86 offices
>worldwide publish more than 1,800 journals and 2,200 new books per year,
>in addition to offering a suite of innovative electronic products, such as
>ScienceDirect (http://www.sciencedirect.com/), MD Consult
>(http://www.mdconsult.com/), Scopus (http://www.news.scopus.com/),
>bibliographic databases, online reference works and subject specific
>portals.
>
>Elsevier (http://www.elsevier.com/) is a global company headquartered in
>Amsterdam, The Netherlands and has offices worldwide. The company is part
>of Reed Elsevier Group plc (http://www.reedelsevier.com/), a world-leading
>publisher and information provider. Operating in the science and medical,
>legal, education and business-to-business sectors, Reed Elsevier provides
>high-quality and flexible information solutions to users, with increasing
>emphasis on the Internet as a means of delivery. Reed Elsevier's ticker
>symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and
>ENL (New York Stock Exchange).
>
>For more information, please contact:
>Lynne Herndon (lherndon at cell.com <mailto:lherndon at cell.com>)
>Cell Press President and CEO
>(617) 397-2815
>
>Emilie Marcus (emarcus at cell.com <mailto:emarcus at cell.com>)
>Cell Press Executive Editor and Editor of Cell
>(617) 661-7057
Emily McElroy
Collection Development & Acquisitions Librarian
University of Oregon Libraries
1299 University of Oregon
Eugene, OR 97403-1299
phone: 541-346-1646
fax: 541-346-3485
emcelroy at darkwing.uoregon.edu
_______________________________________________
Sigsti-l mailing list
Sigsti-l at asis.org
http://mail.asis.org/mailman/listinfo/sigsti-l
More information about the Sigsti-l
mailing list